Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

How comorbidities affect SARS-CoV-2 viral entry

Almost from the start of the current COVID-19 pandemic, it has become clear that individuals suffering from other medical conditions like diabetes, cardiovascular disease, and lung disease are far more likely to contract the infection and to have a poorer outcome.

28 May 2020

PCR and CRF partner to deliver practical education in virtual format

PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020) and CRF’s TVT Connect meeting (June 18-28, 2020).

28 May 2020

Study: Women less likely to have cardiovascular disease, and die of it, than men

A huge study of more than 160,000 people in 21 countries has found that women are less likely to have cardiovascular disease, and die of it, than men.

20 May 2020

SCAI publishes position statement addressing optimal PCI treatment for complex CAD

The Society for Cardiovascular Angiography and Interventions has published a position statement addressing optimal percutaneous coronary intervention treatment of patients with complex coronary artery disease.

14 May 2020

SCAI releases recommendations for managing patients with out-of-hospital cardiac arrest

The Society for Cardiovascular Angiography and Interventions has released an expert consensus statement describing recommendations for the management of patients with out-of-hospital cardiac arrest.

14 May 2020

Study shows why older individuals are vulnerable to COVID-19

A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why older individuals and those with preexisting medical conditions are vulnerable populations, investigators report.

13 May 2020

Study provides indications and techniques of lower extremity revascularization

Lower extremity artery disease is a leading cause of morbidity and mortality worldwide, affecting hundreds of millions of people.

7 May 2020

Is ACEI, ARB use linked to testing positive for COVID-19?

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.

6 May 2020

AHA emphasizes the importance of managing cardiovascular disease during pregnancy

A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.

5 May 2020

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

30 Apr 2020

Apple Watch ECG app may detect coronary ischemia

Digitization can do a lot in medicine, even save lives. This is shown by the specific case of an 80-year-old patient in Mainz.

30 Apr 2020

Free clinics try to fill gaps as COVID sweeps away job-based insurance

The 55-year-old man, who moved to Tupelo from Georgia to take care of his dying father nearly four years ago, found manufacturing work that came with health insurance.

30 Apr 2020

COVID-19 and immunodeficiency

COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.

21 Apr 2020

Novel 3D fusion imaging improves diagnosis of coronary artery disease

Coronary artery disease is the most common type of heart disease, according to the Centers for Disease Control and Prevention. About 18.2 million adults in the United States have coronary artery disease.

16 Apr 2020

3D fusion imaging improves coronary artery disease diagnosis

Researchers have overcome limitations of combining CT and MRI with a 3D imaging method for diagnosing coronary artery disease.

16 Apr 2020

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Type 2 diabetes affects treatment options for patients who have both coronary artery disease and T2D, according to a new American Heart Association Scientific Statement, published today in the Association's flagship journal Circulation.

13 Apr 2020

People with type 2 diabetes and heart disease may benefit from newer therapies

Type 2 diabetes (T2D) may affect treatment options for patients who have both coronary artery disease (CAD) and T2D.

13 Apr 2020

New guidance on treating COVID-19 patients with heart attack signs

Much remains unknown about COVID-19, but many studies already have indicated that people with cardiovascular disease are at greater risk of COVID-19.

9 Apr 2020

CVIA publishes new issue that brings key research papers from top cardiologists

The journal Cardiovascular Innovations and Applications (CVIA) has just published a new issue, Volume 4 Issue 3 with an invitation to join the International Brugada Electrocardiographic Indices Registry.

1 Apr 2020

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

31 Mar 2020